CHU De Caen; Service De Neurologie Dejerine

Caen 14033

0 studies enrolling now · 2 studies all time

What they study most

Alzheimer's Disease, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Completed
• A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease — Completed